Delivery Order SPE2DB20D3103-SPE2DB25FQ3E1
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units, with a ceiling value of $4,916.56. The contract is a firm fixed price delivery order with an ultimate completion date of June 30, 2025, and was awarded on a competitive, non-set-aside basis. The vendor will perform this work from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on August 18, 2025, with a ceiling value of $8,385.46. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order contains no set-aside designation, allowing full and open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 units, with a contract value of $1,042.71. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will occur at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $2,497.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with completion targeted for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Oseltamivir Phosphate 45 mg capsules in unit dose packaging of 10 units. This contract represents a firm fixed price delivery order with a ceiling value of $4,604.97 and an ultimate completion date of August 20, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,872.90 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza, with a ceiling value of $50,852.35 and a performance period ending on January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under the Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.99 firm fixed-price contract is for the delivery of 4,566,703,864 units of Oseltamivir Phosphate 75 mg capsules, a medication used for the treatment of influenza. The contract has a performance period through December 13, 2024 and does not...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3E1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, represents a critical pharmaceutical commodity for military healthcare operations and readiness. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's established role as a major pharmaceutical distributor and prime vendor demonstrates the company's capability to fulfill federal medical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.9k | 9/16/25 |